Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents--a review.

Abdel-Rahman RM.

Pharmazie. 2001 Jan;56(1):18-22. Review.

PMID:
11210661
[PubMed - indexed for MEDLINE]
2.
3.

Synthesis of some new heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anti-cancer drugs, Part II.

Abdel-Rahman RM, Morsy JM, el-Edfawy S, Amine HA.

Pharmazie. 1999 Sep;54(9):667-71.

PMID:
10522270
[PubMed - indexed for MEDLINE]
4.

Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, part III.

el-Gendy Z, Morsy JM, Allimony HA, Ali WR, Abdel-Rahman RM.

Pharmazie. 2001 May;56(5):376-83.

PMID:
11400552
[PubMed - indexed for MEDLINE]
5.

Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.

Abdel-Rahman RM, Morsy JM, Hanafy F, Amene HA.

Pharmazie. 1999 May;54(5):347-51.

PMID:
10368828
[PubMed - indexed for MEDLINE]
6.

Microwave assisted synthesis of some new fused 1,2,4-triazines bearing thiophene moieties with expected pharmacological activity.

Saad HA, Youssef MM, Mosselhi MA.

Molecules. 2011 Jun 15;16(6):4937-57. doi: 10.3390/molecules16064937.

PMID:
21677606
[PubMed - indexed for MEDLINE]
Free Article
7.

Synthesis of some new heterobicyclic compounds containing spiro-1,2,4-triazine moiety as potential anti HIV and anticancer agents.

Abdel-Rahman RM, Seada M, Fawzy M, el-Baz I.

Boll Chim Farm. 1994 Jun;133(6):374-80.

PMID:
7917184
[PubMed - indexed for MEDLINE]
8.

Synthesis of some new heterobicyclic compounds containing spiro-1,2,4-triazine moiety as potential anti-HIV and anticancer agents.

Abdel-Rahman RM, Seada M, Fawzy M, el-Baz I.

Pharmazie. 1994 Nov;49(11):811-4.

PMID:
7838866
[PubMed - indexed for MEDLINE]
9.

Anti-AIDS agents. Part 47: Synthesis and anti-HIV activity of 3-substituted 3',4'-Di-O-(S)-camphanoyl-(3'R,4'R)-(+)-cis-khellactone derivatives.

Xie L, Allaway G, Wild C, Kilgore N, Lee KH.

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2291-3.

PMID:
11527717
[PubMed - indexed for MEDLINE]
10.

Chemistry and biology of salicylihalamide a and related compounds.

Yet L.

Chem Rev. 2003 Nov;103(11):4283-306. Review. No abstract available.

PMID:
14611264
[PubMed - indexed for MEDLINE]
11.

Anti-AIDS agents part 41: synthesis and anti-HIV activity of 3',4'-di-o-(-)-camphanoyl-(+)-cis-khellactone (DCK) lactam analogues.

Yang ZY, Xia Y, Xia P, Brossi A, Cosentino LM, Lee KH.

Bioorg Med Chem Lett. 2000 May 15;10(10):1003-5.

PMID:
10843202
[PubMed - indexed for MEDLINE]
12.

Role of uncondensed 1,2,4-triazine derivatives as biocidal plant protection agents--a review.

Abdel-Rahman RM.

Pharmazie. 2001 Mar;56(3):195-204. Review.

PMID:
11265582
[PubMed - indexed for MEDLINE]
13.

Privileged s-triazines: structure and pharmacological applications.

Shah DR, Modh RP, Chikhalia KH.

Future Med Chem. 2014 Mar;6(4):463-77. doi: 10.4155/fmc.13.212. Review.

PMID:
24635525
[PubMed - indexed for MEDLINE]
14.

1,2,4-triazine analogs as novel class of therapeutic agents.

Kumar R, Sirohi TS, Singh H, Yadav R, Roy RK, Chaudhary A, Pandeya SN.

Mini Rev Med Chem. 2014 Feb;14(2):168-207. Review.

PMID:
24479860
[PubMed - indexed for MEDLINE]
15.

Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.

Mahajan DH, Pannecouque C, De Clercq E, Chikhalia KH.

Arch Pharm (Weinheim). 2009 May;342(5):281-90. doi: 10.1002/ardp.200800149.

PMID:
19415671
[PubMed - indexed for MEDLINE]
16.

Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.

Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C.

Chem Biodivers. 2009 Apr;6(4):561-8. doi: 10.1002/cbdv.200800163.

PMID:
19353537
[PubMed - indexed for MEDLINE]
17.

Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.

Xiong YZ, Chen FE, Balzarini J, De Clercq E, Pannecouque C.

Eur J Med Chem. 2008 Jun;43(6):1230-6. Epub 2007 Aug 11.

PMID:
17869386
[PubMed - indexed for MEDLINE]
18.

Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone analogues.

Xie L, Takeuchi Y, Cosentino LM, McPhail AT, Lee KH.

J Med Chem. 2001 Mar 1;44(5):664-71.

PMID:
11262077
[PubMed - indexed for MEDLINE]
19.

Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.

Bekircan O, Küxük M, Kahveci B, Kolayli S.

Arch Pharm (Weinheim). 2005 Aug;338(8):365-72.

PMID:
16041836
[PubMed - indexed for MEDLINE]
20.

FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Kim JT, Hamilton AD, Bailey CM, Domaoal RA, Wang L, Anderson KS, Jorgensen WL.

J Am Chem Soc. 2006 Dec 6;128(48):15372-3. Erratum in: J Am Chem Soc. 2007 Mar 14;129(10):3027. Domoal, Robert A [corrected to Domaoal, Robert A].

PMID:
17131993
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk